Trinity Biotech Gross Profit Growth & History (TRIB)
Trinity Biotech's gross profit was $16.9M for fiscal 2025.
View full Trinity Biotech company overviewTrinity Biotech annual gross profit history
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $16.9M | −$4.6M | −21.24% |
| 2024 | 2024-12-31 | $21.4M | $2.0M | +10.24% |
| 2023 | 2023-12-31 | $19.4M | $2.2M | +12.64% |
| 2022 | 2022-12-31 | $17.3M | −$16.2M | −48.38% |
| 2021 | 2021-12-31 | $33.5M | −$15.1M | −31.14% |
| 2020 | 2020-12-31 | $48.6M | $10.5M | +27.44% |
| 2019 | 2019-12-31 | $38.1M | −$3.3M | −8.03% |
| 2018 | 2018-12-31 | $41.4M | −$441,000 | −1.05% |
| 2017 | 2017-12-31 | $41.9M | −$1.6M | −3.67% |
| 2016 | 2016-12-31 | $43.5M | −$3.0M | −6.51% |
| 2015 | 2015-12-31 | $46.5M | — | — |
Trinity Biotech quarterly gross profit
Q2.17
Q2.18
Q4.24
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $4.9M | — | — |
| Q2 2018 | 2018-06-30 | $10.8M | −$11,000 | −0.10% |
| Q2 2017 | 2017-06-30 | $10.8M | — | — |
Trinity Biotech gross profit trends
Over the last five fiscal years, Trinity Biotech's gross profit decreased from $48.6M to $16.9M, a change of −$31.7M. The latest reported quarter, Q4 2024, shows $4.9M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Trinity Biotech source filings ↗